App is temporarily unavailable
Description
支持用户在线发起筹药申请；
支持用户在线查询筹药进度；
支持在线咨询客服。
支持用户在线查询筹药进度；
支持在线咨询客服。
Screenshots
医药筹 FAQ
-
Is 医药筹 free?
Yes, 医药筹 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 医药筹 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 医药筹 cost?
医药筹 is free.
-
What is 医药筹 revenue?
To get estimated revenue of 医药筹 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in India yet.
Ratings History
医药筹 Reviews
Keywords
医药筹 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
大专家医生版
|
Unlock
|
Unlock
|
0
|
|
3 weeks ago | |
N/A
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
易加医医生端-收治随访肿瘤患者
肿瘤专科医生的移动助手
|
Unlock
|
Unlock
|
0
|
|
11 months ago | |
安新研
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
乐问医学
乐问医学-做大数据+AI与生命科学的链接者
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
和缓名医（医生版）-D2D医生移动协作平台
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
智连星医
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
齐研荟萃
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
精准检测平台
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
咚咚肿瘤科
临床决策、干货经验、知识和结论
|
Unlock
|
Unlock
|
0
|
|
2 months ago |
医药筹 Installs
Last 30 days
医药筹 Revenue
Last 30 days医药筹 Revenue and Downloads
Gain valuable insights into 医药筹 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- ZhongCi Network Technology Co
- Languages
- English, Chinese
- Recent release
- 4.0.1 (1 year ago )
- Released on
- Feb 20, 2019 (5 years ago )
- Also available in
- China , Pakistan , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Israel , Poland , Portugal , Romania , Russia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , India , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , United Arab Emirates
- Last Updated
- 9 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.